Guru Ownership Trend
Guru Analysis for Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (HBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.32 M.
Top institutional holders include Renaissance Technologies and Mario Gabelli.
Institutional sentiment is currently Bullish. This is evidenced by a $150,132.9 net inflow during the quarter.
Recent activity highlights Mario Gabelli who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Harvard Bioscience, Inc. (HBIO)
Major holders include Renaissance Technologies ($683,006), Mario Gabelli ($38,122), Steven Cohen ($9,843). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.09 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $150,132.9, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in HBIO during the most recent reporting period.
Yes, 2 managers opened new positions in HBIO, and 1 increased their existing holdings. The total reported buy value was $150,132.9.